SCHINDLER
6.3.2019 20:03:11 CET | Business Wire | Press release
Today, Schindler announced the formation of BuildingMinds, a start-up created to optimize the management of real estate assets through a software-as-a-service platform.
Partnering with Microsoft, BuildingMinds is using Microsoft’s Azure and Dynamics 365 cloud platforms. Building owners will benefit from the combination of Microsoft’s intelligent cloud and business applications and Schindler’s domain knowledge in servicing real estate customers globally.
BuildingMinds will offer a one-stop service platform for real estate asset optimization, transforming the way buildings are managed in the real estate sector. The start-up will develop a fully integrated, product-agnostic, cloud solution that improves transparency and operational efficiency by allowing building owners to centrally manage all their properties and service providers.
Founded in Berlin, Europe’s prominent hub for property technology start-ups, BuildingMinds will serve customers worldwide and plans to grow its team to over 100 digital experts by year-end.
“Our partnership combines Schindler’s world-class expertise in the building management industry with the power of Microsoft technology to drive innovation across the sector. BuildingMinds will offer a range of smart building solutions, tailored to help building owners around the world facing daily operational challenges,” said Jean-Philippe Courtois, Executive Vice President and President, Microsoft Global Sales, Marketing and Operations.
“Today, properties use different supplier applications often unconnected with one another. As digitization advances, real estate owners face the challenge of managing the data locked in such an array of diverse applications within their portfolio of buildings,” said Jens Mueller, Chief Operating Officer of BuildingMinds.
“The demand for data-driven intelligence in building management and real estate asset optimization is significant and growing. Combining our industry insights with our digitization expertise will enable BuildingMinds to play a role in leading the change taking place in the sector,” said Silvio Napoli, Chairman of the Schindler Group. “This will close a long-standing gap in the advent of smart buildings, and we are pleased to be partnering with a global leader such as Microsoft on this pivotal initiative.”
Market research firm Orbis Research forecasts that the global smart-building market is expected to grow from around USD 8 billion in 2016 to around USD 58 billion by 2023. To tap into the opportunities of digitization, real estate companies are investing in new solutions that integrate their properties with their suppliers’ ecosystems and broader asset portfolio. By joining forces, BuildingMinds and Microsoft are bringing together the capabilities needed to accelerate this transformation.
BuildingMinds will operate as a stand-alone company within the Schindler Group. As its sole shareholder, Schindler has allocated funding of up to EUR 150 million to the start-up, a quarter of which it expects to expense in 2019.
About BuildingMinds
BuildingMinds enables the transformation of real estate into smart buildings, connecting real estate assets across the whole value chain through its fully integrated one-stop cloud platform. www.buildingminds.com
About Microsoft
Microsoft enables digital transformation for the era of an intelligent cloud and an intelligent edge. Its mission is to empower every person and every organization on the planet to achieve more. www.microsoft.com
About Schindler
Founded in Switzerland in 1874, the Schindler Group is a leading global provider of elevators, escalators, and related services. Schindler mobility solutions move more than one billion people every day all over the world.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190306005705/en/
Contact:
For further information: Nelly Keune, Chief Communications Officer Tel. +41 41 445 30 60, nelly.keune@schindler.com Marco Knuchel, Head of Investor Relations Tel. +41 41 445 30 61, marco.knuchel@schindler.com
Zugerstrasse 13 6030 Ebikon Switzerland
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom